ATF-2(ATF2)antibody

ATF-2(ATF2)antibody
Cat.#: 1242-1
Rabbit Monoclonal Antibody
Clone ID: E242
Swiss Prot: P15336
Mol Weight: 70kDa
Size: 100ul

Description
ATF-2 (activating transcription factor-2, CRE-BP1) is a transcription factor that binds the cAMP response element (CRE) and AP-1 response element and is abundantly expressed in the brain. Various forms of cellular stress, including genotoxic agents, inflammatory cytokines, and UV irradiation, stimulate the transcriptional activity of ATF-2 (2). SAPK and p38 MAPK can activate, in response to cellular stress, ATF-2 by phosphorylating this protein at Thr69 and Thr71. Mutations of these sites result in the loss of stress-induced transcription by ATF-2 (2-4).

Recommended Applications
WB, IHC, ICC, IP

Applications and Recommended Dilution Factors
WB: 1:1,000 - 10,000
IHC: 1:100
ICC: 1:250-1:500
IP: 1:50

Species Reactivity
Human

Cross reactivity determined by western blot only.

Products Data 

Specificity
A synthetic peptide corresponding to residues N-terminus of human ATF-2 was used as immunogen. The antibody does not cross-react with other ATF family members.

Storage Condition and Buffer
Store at -20 °C. Buffer: 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Alternative Names
ATF2 antibody, CRE-BP1 antibody, CREB2 antibody, HB16 antibody, MGC111558 antibody, TREB7 antibody, Cyclic AMP-dependent transcription factor ATF-2 antibody, HB16 antibody, cAMP response element-binding protein CRE-BP1 antibody

Description References
1. Maekawa, T., et al. Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J. 8: 2023
2. Gupta, S., et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389
3. van Dam, H., et al. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14: 1798
4. Livingstone, C., et al. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14: 1785

Product References
1. Mandell JW, Glass G, Gianchandani EP, et al, Dephosphorylation of β-Arrestin 1 in Glioblastomas ,J Neuropathol Exp Neurol. 68 (2009) 535-541
[Application: WB, IHC]
2. Balabanian K, Levoye A, Klemm L, et al, Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling ,J. Clin. Invest. 118 (2008) 1074–1084
[Application: WB]